RANK-ligand inhibition to combat sarcopenia with underlying osteoporosis: a study protocol for a randomized, double-blind, double-dummy, active-controlled trial
ClinicalTrials.gov, NCT06643780. Registered on 16 October 2024. (Retrospectively registered and no protocol changes were made since the recruitment was started for this study).
Authors
- Wing‐Hoi Cheung (ORCID: https://orcid.org/0000-0003-3247-8255)
- Wing Hong Liu (ORCID: https://orcid.org/0000-0003-0879-7205)
- Sheung Wai Law (ORCID: https://orcid.org/0000-0001-7923-0164)
- Ronald Man Yeung Wong (ORCID: https://orcid.org/0000-0001-5615-6627)
- Pui Yan Wong (ORCID: https://orcid.org/0000-0001-6513-1843)
- Can Cui (ORCID: https://orcid.org/0000-0001-9328-4521)
- Timothy Kwok (ORCID: https://orcid.org/0000-0001-9253-3549)
- Ning Zhang (ORCID: https://orcid.org/0000-0002-9513-9288)
- Chaoran Liu
- Ning Tang
- Raymond Chung Wai Wan
Institutions
- Chinese University of Hong Kong (HK)
- Prince of Wales Hospital (CN)
Publication Details
- Journal
- Trials
- Published
- 2025-08-04
- DOI
- https://doi.org/10.1186/s13063-025-08976-7
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Health and Medical Research Fund